Document:

Employment Agreement by and between the Company and Edward K. Wissing

 Exhibit 10.9(ee) 
  
 EMPLOYMENT AGREEMENT 
  
 This EMPLOYMENT AGREEMENT, dated and effective as of August 9, 2004 (the “Agreement”), by and between PEDIATRIC SERVICES OF AMERICA, INC., a
Delaware corporation (“Company”), and EDWARD K. WISSING (“Executive”); 
  
 W I T N E S S E T H: 
  
 WHEREAS, the Company is in the process of searching for an permanent Chief Executive Officer and desires to employ Executive as its interim Chief Executive Officer upon the terms and subject to the conditions set forth herein; 

 
 NOW, THEREFORE, in consideration of the premises and the mutual agreements
contained herein, the Company and Executive hereby agree as follows: 
  
 Article I. 
  
 DEFINITIONS 
  
 The terms set forth below have the following meanings (such meanings to be
applicable to both the singular and plural forms, except where otherwise expressly indicated): 
  
 1.1 “Accrued Base Salary” means the amount of Executive’s Base Salary which is accrued but not yet paid as of a Date of Termination.

  
 1.2 “Affiliate” means any Person directly or
indirectly controlling, controlled by or under direct or indirect common control with, the Company. For purposes of this definition, the term “control” when used with respect to any Person means the power to direct or cause the direction
of management or policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise. 
  
 1.3 “Agreement” — see the recitals to this Agreement. 
  
 1.4 “Agreement Date” means the date that is specified in the recitals to this Agreement. 
  
 1.5 “Base Salary” — see Section 4.1. 
  
 1.6 “Beneficiary” — see Section 10.3. 
  
 1.7 “Board” means the Board of Directors of the Company.

  
 1.8 “Cause” means an act or acts by an
individual involving personal dishonesty, willful misconduct, moral turpitude, intentional failure to perform stated duties, willful violation of any law, rule or regulation (other than traffic violations or similar offenses), the use for profit or
disclosure to unauthorized persons of confidential information or trade secrets of the 

 Company or its Affiliates, the breach of any contract with the Company, the unlawful trading in the securities of the
Company or of another corporation based on information gained as a result of the performance of services for the Company, a felony conviction or the failure to contest prosecution for a felony, embezzlement, fraud, deceit or civil rights violations,
any of which acts causing the Company or any subsidiary liability or loss, as determined by the Committee in its sole discretion. 
  
 1.9 “Committee” means the Compensation Committee of the Board. 
  
 1.10 “Common Stock” means the common stock, $0.01 par value, of the Company. 
  
 1.11 “Company” — see the recitals to this Agreement.

  
 1.12 “Date of Termination” means the
effective date of a Termination of Employment for any reason, including death or disability, whether by either of the Company or by Executive. 
  
 1.13 “Employment Period” — see Section 3.1. 
  

1.14 “Executive” — see the recitals to this Agreement. 
  
 1.15 “NQDC Plan” — see Section 6.2. 
  
 1.16 “Option” means an option to purchase shares of Common Stock. 
  
 1.17 “Option Plan” — see Section 5.1. 
  
 1.18 “Person” means any individual, sole proprietorship,
partnership, joint venture, trust, unincorporated organization, association, corporation, institution, public benefit corporation, entity or government instrumentality, division, agency, body or department. 
  
 1.19 “Restricted Lines of Business” — see Section
9.7(b). 
  
 1.20 “Restricted Period” — see
Section 9.7(a). 
  
 1.21 “Restricted Territory”
— see Section 9.7(c). 
  
 1.22 “Termination of
Employment” means a termination by the Company or by Executive of Executive’s employment by the Company. 
  
 1.23 “Withholding Taxes” means any United States federal, state, local or foreign withholding taxes and other deductions required to be
paid in accordance with applicable law by reason of compensation received pursuant to this Agreement. 
  
 Wissing Employment Agreement 
 Page 2 of 11 Pages 

 Article II. 
  
 DUTIES 
  
 2.1 Duties. Subject to the provisions of Article VII, the Company shall employ Executive during the Employment Period as its interim Chief
Executive Officer. Executive is currently serving as a member and Chairman of the Board, and it is contemplated that he will continue to serve in these capacities during the Employment Period. During the Employment Period, Executive shall perform
the duties properly assigned to him hereunder and described in Exhibit A to this Agreement, shall devote his business time, attention and effort primarily to the affairs of the Company and shall use his reasonable best efforts to promote the
interests of the Company. Executive agrees to spend at least three (3) days per week at the Company’s headquarters in Norcross, Georgia. 
  
 2.2 Other Activities. Executive may serve on corporate, civic or charitable boards or committees, deliver lectures, fulfill speaking engagements,
teach at educational institutions, or manage personal investments; provided that such activities do not individually or in the aggregate significantly interfere with the performance of his duties under this Agreement. 
  
 Article III. 
  
 EMPLOYMENT PERIOD 
  
 3.1 Employment Period. Subject to Section 3.2 and the termination provisions hereinafter provided, the term of Executive’s employment under
this Agreement (the “Employment Period”) shall begin on the Agreement Date and end on December 31, 2005. Executive shall be an “at will” employee of the Company at all times, and both the Company and Executive may terminate the
employment arrangement under this Agreement at any time upon thirty (30) days’ written notice to the other party, provided however that in the event of such termination, the provisions of Article VIII shall apply. 
  
 3.2 Extensions of Employment Period. At the end of the Employment
Period specified in Section 3.1, the parties may, by mutual consent, extend the Employment Period under this Agreement. 
  
 Article IV. 
  
 CASH COMPENSATION 
  
 4.1 Salary. The Company shall pay Executive in accordance with its normal payroll practices (but not less frequently than monthly) an annual salary at a rate of $240,000.00 per year (“Base Salary”). 
  
 Wissing Employment Agreement 
 Page 3 of 11 Pages 

 Article V. 
  
 OPTION GRANTS 
  
 5.1 Initial Option Grant. Subject to the approval of the Committee, the Company shall grant to Executive under the Pediatric Services of America.,
Inc. Stock Option Plan (the “Option Plan”) an Option to purchase 100,000 shares of Common Stock at the fair market value of the Common Stock (as defined in the Option Plan) as of the date of grant, provided that any such grant shall be
effective as of the date of Committee approval. Such options shall be nonqualified and shall be subject to the same terms and conditions as for options granted to other similarly-situated employees and the provisions of the Option Plan, provided
that the Option shall vest and become fully exercisable one year following the Agreement Date and remain exercisable through the day next preceding the day which is the tenth (10th) anniversary of the date of grant. 
  
 Article VI. 
  
 OTHER BENEFITS 
  
 6.1 Participation in Employee or Fringe Benefit Plans. Except as otherwise specified or to the extent modified in this Article VI, in addition to Base Salary and Option grants specified in Article VI, Executive shall be entitled to
participate during the Employment Period in all employee benefit plans, practices, policies and programs that are from time to time applicable to other senior executives of the Company in accordance with the terms and conditions of such plans,
practices, policies and programs as in effect from time to time. 
  
 6.2 Participation in Cash Incentive Plans and Nonqualified Deferred Compensation Plan. Notwithstanding anything in this Agreement to the contrary, Executive shall not be eligible to participate in any cash incentive programs
sponsored by the Company, nor to receive any allocation of Company contributions under Section 3.2 of the Pediatric Services of America, Inc. Nonqualified Deferred Compensation Plan (the “NQDC Plan”). Except as otherwise specified in this
Section 6.2, nothing in this Section 6.2 is intended to prevent Executive from participating in the NQDC Plan. 
  
 6.3 Vacation. During the Employment Period, Executive shall be entitled to 3 weeks’ annual paid vacation time, pro rated as necessary for
partial years of employment. 
  
 6.4 Expenses. During the
Employment Period, Executive shall be entitled to receive prompt reimbursement for all reasonable employment-related expenses incurred by Executive upon the receipt by the Company of an accounting for such expenses in accordance with practices,
policies and procedures applicable to other senior executives of the Company. It is anticipated that Executive will not be residing in the Atlanta, Georgia area during the Employment Period, and such expenses shall include, without limitation,
reasonable travel and temporary living expenses incurred by Executive in carrying out his duties under this Agreement. 
  
 Wissing Employment Agreement 
 Page 4 of 11
Pages 

 6.5 Modification of Employee or Fringe Benefit Plans. Nothing in this Agreement is intended to
prevent the Company from modifying or terminating any employee benefit plan, practice, policy or program in effect on the Agreement Date or thereafter during the Employment Period, in accordance with the terms thereof and of applicable law.

  
 Article VII. 
  
 EMPLOYMENT OF NEW CEO 
  
 7.1 Employment of New CEO. During the Employment Period, the Company
has the right to hire another person to serve as its permanent Chief Executive Officer. At such time, at the request of the Board, Executive shall tender his resignation as Chief Executive Officer of the Company. In such event, if the new Chief
Executive Officer is a candidate procured by Executive in accordance with his duties under Section 2.1 (as determined by the Committee in its discretion), Executive shall continue in employment with the Company, but in an alternative capacity and
with different duties, as specified by the Board, for the remainder of the Employment Period, and except for the change of position and duties under Section 2.1, this Agreement shall remain in full force and effect in accordance with its terms.

  
 Article VIII. 
  
 TERMINATION 
  
 8.1 Termination for Cause or Termination by Executive. If the Company terminates Executive’s employment for
Cause or Executive terminates his employment for any reason, the Company shall pay to Executive immediately after the Date of Termination an amount equal to the Executive’s Accrued Base Salary, and Executive shall be entitled to any other then
vested payments or benefits under Company-sponsored employee benefit plans (including, without limitation, the Option Plan and the NQDC Plan) that may become due and payable to him or his Beneficiaries, as the case may be, on or after the Date of
Termination in accordance with the provisions of the respective plans (including, without limitation, those provisions that govern forfeitures in the event of termination for cause). Executive shall not be entitled to any other payments or benefits
from the Company. 
  
 8.2 Termination by the Company Without
Cause. If the Company terminates Executive’s employment for any reason other than Cause or his replacement as the Company’s Chief Executive Officer in accordance with Article VII (including, without limitation, termination for death or
disability), the Company shall continue to pay the Executive (or his Beneficiaries, as the case may be), as a severance payment, an amount equal to his Base Salary in accordance with the Company’s normal payroll practices as if he remained
employed by the Company following his Date of Termination for the remainder of the original Employment Period contemplated in Section 3.1. In addition, Executive shall be entitled to any other then vested payments or benefits under Company-sponsored
employee benefit plans (including, without limitation, the Option Plan and the NQDC Plan) that may become due and payable to him or his Beneficiaries, as the case may be, on or after the Date of Termination in accordance with the provisions of the
respective plans. Executive shall not be entitled to any other payments or benefits from the Company. 
  
 Wissing Employment Agreement 
 Page 5 of 11 Pages 

 Article IX. 
  
 RESTRICTIVE COVENANTS 
  
 9.1 Background. During his employment with the Company, Executive will acquire intimate knowledge of all aspects of the Company’s business,
including its strategic plans and its financial information. In his role as Chief Executive Officer of the Company, Executive will also develop ongoing business relationships with Medicaid programs in the states in which the Company does business,
as well as with the managed care companies with which the Company does business. Because of his knowledge and his relationships, the Company would suffer significant and irreparable harm if Executive were to engage in the conduct prohibited by this
Article IX. Accordingly, Executive agrees to the restrictions specified in this Article IX. 
  
 9.2 Noncompetition. During the Restricted Period, Executive will not, directly or indirectly, on his own behalf or on behalf of another, acquire an ownership interest in or act in the capacity of a director,
officer, manager, supervisor, partner or consultant for any business which engages in one or more of the Restricted Lines of Business (as defined below) in the Restricted Territory (as defined below). This paragraph shall not restrict Executive from
acquiring not more than two percent (2%) of the common stock of any publicly-traded corporation. Following his Date of Termination, this paragraph also shall not restrict Executive from becoming employed by a company which engages in the Restricted
Lines of Business, as long as Executive’s services for such employer are entirely separate from and unrelated to the Restricted Lines of Business and Executive otherwise complies with the confidentiality and nonrecruitment restrictions of this
Article IX. 
  
 9.3 Nonrecruitment of Employees. During the
Restricted Period, Executive will not, directly or indirectly, on his own behalf or on behalf of another, solicit for employment or hire any employee of the Company or its subsidiaries or otherwise induce any employee of the Company or its
subsidiaries to terminate his/her employment. 
  
 9.4
Confidentiality. During Executive’s employment with the Company, he has had access to and become familiar with information that the parties acknowledge to be confidential, valuable and uniquely proprietary information. During the
Restricted Period, Executive shall neither use nor disclose for any purpose any confidential or proprietary information relating to the financial condition or the manner of doing business or the property of the Company, its customers and business
associates, other than to his attorney for the purpose of securing legal advice concerning this Agreement. In the case of information which constitutes trade secrets under applicable state law, Executive agrees to maintain the secrecy of such
information for so long as the law permits such information to be protected from disclosure. 
  
 9.5 Return of Property. Executive hereby represents and warrants that, except as otherwise provided in this Agreement, no later than his Date of Termination, he will return to the Company all documents or other
property (including copies thereof) of any nature which relate to or contain information concerning the Company or its Affiliates, or its or their customers and business associates, as well as any other equipment or property belonging to the Company
or its Affiliates. 
  
 Wissing Employment Agreement 
 Page 6 of 11 Pages 

 9.6 Nondisparagement. During the Restricted Period, Executive will not make any statements that
are derogatory or disparaging towards the Company or its Affiliates or the Company’s management, products, or services, and the Company will not make any statements that are derogatory or disparaging toward Executive or his professional
reputation. 
  
 9.7 Definitions. For purposes of this
Article IX, the following terms shall have the following meanings: 
  
 (a) “Restricted Period” means that period of time beginning on the Agreement Date and ending on the second anniversary of Executive’s Date of Termination. 
  
 (b) “Restricted Lines of Business” include
any business line that the Company (directly or through its Affiliates) engages in as of the Agreement Date, more specifically described as follows: 
  
 (1) Pediatric Nursing Services, including private duty home nursing services for pediatric patients with illnesses and conditions such as
bronchopulmonary dysplasia, digestive and absorptive diseases, congenital heart defects and other cardiovascular disorders, cancer, cerebral palsy, cystic fibrosis, obstructive and restrictive pulmonary disease such as bronchitis or asthma,
endocrinology disorders, hemophilia, orthopedic conditions and post surgical needs, as well as intermittent home visits for patients with a lower level of acuity. In addition, these services include staffing contracts for educational institutions
and systems and pediatric skilled nursing facilities. 
  
 (2) Care centers similar to the Company’s Prescribed Pediatric Extended Care Centers, which provide, among other services, daily medical care and physical, occupational, and other forms of therapy for medically fragile, chronically ill
and developmentally delayed children. 
  
 (3)
Specialty Pharmacy and Infusion Therapy Services, which provide pharmaceutical products and services for patients in the home and physician offices. Pharmacy services include clinical drug management, patient counseling, compliance monitoring, side
effect management, educational information and reimbursement services for complex drug regimens. Specialty pharmacy provides self-injectable biotech medications for chronic diseases. Infusion therapy involves the intravenous administration of
nutrients, antibiotics and other medications. Specialty Pharmacy and Infusion Therapy Services address a wide variety of patient needs including hemophilia therapy, antibiotic and other anti-infective therapies, total parenteral nutrition therapy,
pain management therapy, growth hormone therapy, immunomodular therapy and chemotherapy, osteomyelitis, bacterial endocarditis, cellulitis, septic arthritis wound infections, recurrent infections associated with the kidney and urinary tract, and
AIDS. In addition, these services include therapies provided to terminally or chronically ill patients suffering from acute or chronic pain, patients with impaired or altered digestive tracts due to gastrointestinal illness, patients suffering from
various types of cancer, patients requiring treatment for congestive heart failure and 
  
 Wissing Employment Agreement 
 Page 7 of 11 Pages 

 patients with chronic conditions such as hemophilia, cystic fibrosis, juvenile rheumatoid arthritis,
multiple sclerosis and endocrinology disorders. This line of business also includes a mail order medication service that provides physician prescribed unit dose medications to respiratory therapy patients. 
  
 (4) Respiratory Therapy and Home Medical Equipment Services,
including (A) the rental, sale, delivery and setup in accordance with physician prescriptions of equipment such as ventilators, oxygen concentrators, liquid oxygen systems, high pressure oxygen cylinders, apnea monitors and nebulizers, (B) period
evaluation and maintenance or equipment, and (C) delivery and setup of disposable supplies necessary for the operation of the equipment to pediatric patients in the home. These services are provided to patients with a variety of conditions including
obstructive and restrictive pulmonary diseases, neurologically related respiratory problems, cystic fibrosis, congenital heart defects and cancer. This line of business also provides rental, sale and service of home medical equipment and respiratory
therapy services to adult patients with a focus on high-technology products including, but not limited to, ventilators, oxygen concentrators, liquid oxygen systems, continuous positive airway pressure devices, bi-level assist devices, and oximetry
and apnea monitors. 
  
 (5) Pediatric Case
Management Services. 
  
 (c) Restricted
Territory. The Restricted Territory is the area that is within a 25-mile radius of each location of the Company (including its subsidiaries) as of the Agreement Date. A list of locations as of the Agreement Date is attached as Exhibit B hereto.

  
 9.8 Remedies. The parties acknowledge that the
restrictions contained in this Article IX are reasonable and appropriate for the protection of the Company’s legitimate business interests, and that they will not unduly impair Executive’s ability to find other employment. Executive
acknowledges and agrees that, in the event of a violation of one or more of Executive’s covenants in this Article IX, in addition to and not in lieu of any other remedy to which the Company may be entitled, the Company shall be permitted to
seek and obtain immediate injunctive relief, restraining further violations by Executive, in a court of competent jurisdiction, and without the necessity for posting of a bond or other security. In addition to and not in lieu of any other remedy to
which the Company may be entitled, no further payments or benefits of any kind that would otherwise inure to Executive under this Agreement or (to the extent permitted by applicable law and the provisions of the particular plan) under any employee
benefit plan, practice, policy or arrangement sponsored by the Company shall accrue or be owed, and all future payments and benefits hereunder shall be forfeited, immediately upon Executive’s violation of any of the covenants in Article IX of
this Agreement. 
  
 Wissing Employment Agreement 
 Page 8 of 11 Pages 

 Article X. 
  
 MISCELLANEOUS 
  
 10.1 No Violation. Executive hereby represents and warrants to the Company that neither the execution and delivery of this Agreement nor the
performance by him of his obligations hereunder violates or constitutes a breach of any agreement of undertaking to which Executive is a party or by which he is bound. 
  
 10.2 Taxation and Withholding. Executive acknowledges that payments and benefits hereunder may be taxable and that
the Company makes no representation or warranty regarding the income tax effects of any payment or benefit provided hereunder. Executive shall be solely responsible for his liability with respect to all payments and benefits provided under this
Agreement. The Company may withhold from any amounts payable under this Agreement such Withholding Taxes as shall be required to be withheld pursuant to any applicable law or regulation. 
  
 10.3 Beneficiary. If Executive dies prior to receiving all of the amounts payable to him in accordance with the terms
of this Agreement, such amounts shall be paid to one or more beneficiaries (each, a “Beneficiary”) designated by Executive in writing to the Company during his lifetime, or if no such Beneficiary is designated, to Executive’s estate.
Such payments shall be made in accordance with the terms of this Agreement as if Executive were receiving the payments or benefits, provided that benefits payable pursuant to an employee benefit plan, policy, arrangement or practice covering
Executive or any Beneficiary shall be paid in accordance with the terms of the affected plan. Executive, without the consent of any prior Beneficiary, may change his designation of Beneficiary or Beneficiaries at any time or from time to time by a
submitting to the Company a new designation in writing. 
  
 10.4
Assignment; Successors. The Company may not assign its rights and obligations under this Agreement without the prior written consent of Executive except to a successor of the Company’s business which expressly assumes the Company’s
obligations hereunder in writing. This Agreement shall be binding upon and inure to the benefit of Executive, his estate and Beneficiaries, the Company and the successors and permitted assigns of the Company. 
  
 10.5 Nonalienation. Benefits payable under this Agreement shall not be
subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, charge, garnishment, execution or levy of any kind, either voluntary or involuntary, prior to actually being received by Executive or a Beneficiary,
as applicable, and any such attempt to dispose of any right to benefits payable hereunder shall be void. 
  
 10.6 Severability. If one or more parts of this Agreement are declared by any court or governmental authority to be unlawful or invalid, such
unlawfulness or invalidity shall not invalidate any part of this Agreement not declared to be unlawful or invalid. Any part so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of
such part to the fullest extent possible while remaining lawful and valid. 
  
 10.7 Captions. The names of the Articles and Sections of this Agreement are for convenience of reference only and do not constitute a part hereof. 
  
 Wissing Employment Agreement 
 Page 9 of 11 Pages 

 10.8 Amendment; Waiver. This Agreement shall not be amended or modified except by written
instrument executed by the Company and Executive. A waiver of any term, covenant or condition contained in this Agreement shall not be deemed a waiver of any other term, covenant or condition, and any waiver of any default in any such term, covenant
or condition shall not be deemed a waiver of any later default thereof. 
  
 10.9 Notices. All notices hereunder shall be in writing and delivered by hand, by nationally-recognized delivery service that guarantees overnight delivery, or by first-class, registered or certified mail, return receipt requested,
postage prepaid, addressed as follows: 
  

			
	If to the Company, to:	  	Pediatric Services of America, Inc.
	 	  	310 Technology Parkway
	 	  	Norcross, Georgia 30092
	 	  	Attention:
                                        
    
		
	If to Executive, to:	  	Mr. Edward K. Wissing
	 	  	_____________________________
	 	  	_____________________________

  
 Either party may from time to time
designate a new address by notice given in accordance with this Section. Notice shall be effective when actually received by the addressee. 
  
 10.10 Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which
together will constitute one and the same instrument. 
  
 10.11
Entire Agreement. This Agreement forms the entire agreement between the parties hereto with respect to the subject matter contained in this Agreement and, except as otherwise provided herein, shall supersede all prior agreements, promises and
representations regarding employment, compensation, severance or other payments contingent upon termination of employment, whether in writing or otherwise. 
  
 10.12 Applicable Law. This Agreement shall be interpreted and construed in accordance with the laws of the State of Georgia without regard to its
choice of law principles. 
  
 10.13 Survival of
Executive’s Rights. All of Executive’s rights hereunder, including his rights to compensation and benefits, and his obligations under Article IX hereof, shall survive the termination of Executive’s employment and/or the
termination of this Agreement. 
  
 Wissing Employment Agreement

 Page 10 of 11 Pages 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written. 

 

			
	 PEDIATRIC SERVICES OF AMERICA, INC.
     (A Delaware Corporation)

		
	By:	 	 /s/    ROBERT P. PINKAS

	Its:	 	 Director

	
	Dated: 9/29/04
	
	EXECUTIVE:
	
	 /s/    EDWARD K. WISSING

	Edward K. Wissing

  
 Wissing
Employment Agreement 
 Page 11 of 11 Pages 

 Exhibit A 
  
 DUTIES OF CEO 
  
 1 of 16 Pages 

 Exhibit B 
  
 LIST OF COMPANY LOCATIONS AS OF EXECUTION DATEEmployment Agreement by and between the Company and Daniel J. Kohl

 Exhibit 10.9(ff) 
  
 EMPLOYMENT AGREEMENT 
  

I. 
 PARTIES 
  
 THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between
PEDIATRIC SERVICES OF AMERICA, INC. (“PSA” or “Company”), a Delaware Corporation and DANIEL J. KOHL (“EMPLOYEE”), an individual residing in the State of Georgia, subject to the terms set forth herein.

  
 II. 
 DUTIES OF EMPLOYEE 
  
 2.1 Employment Relationship. PSA agrees to employ EMPLOYEE as an “employee” under all applicable legal standards.
Employee’s start date will be the 15th day of December, 2004. 
  
 2.2 Scope of Employment. EMPLOYEE shall be PSA’s President and Chief Executive Officer, and he shall be responsible for the overall management of PSA and its subsidiaries listed on Appendix 1
(hereinafter referred to as “its subsidiaries”). Employee shall also be responsible for all duties as may be assigned from time to time by the Board of Directors and which are generally required for this position. EMPLOYEE will also
initially serve as a Director on the Board of Directors of PSA (the “Board of Directors”) in the position held by the former Chief Executive Officer. 
  

2.3 Exclusive Services. EMPLOYEE agrees to devote his best efforts, energies and skill to the discharge of the duties and
responsibilities attributable to his position, and to this end, he will devote his full time and attention exclusively to PSA’s business affairs; provided, that EMPLOYEE may (A) serve on corporate, civic or charitable boards and
committees, (B) deliver lectures, fulfill speaking engagements and teach at educational institutions, and (C) manage personal investments, so long as none of the preceding activities interfere or conflict with the performance of EMPLOYEE’s
responsibilities. EMPLOYEE also agrees that he shall not take personal advantage of any business opportunities which arise during his employment and which may benefit PSA. Material facts regarding such opportunities must be promptly reported to the
Chairman of the Board of Directors for consideration by PSA. 
  
 2.4 Conflicts of Interest. EMPLOYEE agrees to avoid actual or potential conflicts of interest with PSA’s business. In this regard, EMPLOYEE agrees (1) not to solicit, offer, or accept any gifts, gratuities, bribes, or
other financial benefit from actual or prospective customers, vendors, suppliers, or competitors; (2) not to have, either directly or indirectly through EMPLOYEE’s family, financial interests in competing or supplying companies which could
affect EMPLOYEE’s duties to PSA; and (3) engage in any other conduct or activities which violates PSA’s policies relating to conflicts of interest. 
  
 2.5 Representation of Ability to Enter Agreement. EMPLOYEE represents and warrants he is under no contractual or other obligation
that would limit or restrict his ability to perform all of his obligations under this Agreement. 
  
 III. 
 COMPENSATION 
  
 3.1 Base Salary. During the first year, the Company shall pay
EMPLOYEE a salary at an annualized rate of three hundred fifty thousand dollars ($350,000.00) per year, gross, payable in bi-weekly installments or in the same regular payments as is the practice for other salaried employees of the Company. The
Employee’s performance will be evaluated annually and salary increases will be based on 
  

 1 

 performance and business conditions as determined by the Compensation Committee of the PSA Board of Directors (the
“Compensation Committee”) in accordance with Company policy and practice. Any increase in the Base Salary shall not serve to limit or reduce any other obligation to EMPLOYEE under this Agreement. The “Base Salary” as used herein
shall refer to the Base Salary as so increased, and, in any event, Base Salary shall not be subject to reduction during EMPLOYEE’s employment by PSA. 
  
 3.2. Bonus. EMPLOYEE shall be entitled to earn an annual bonus in an amount up to 60% of EMPLOYEE’S Base Salary for fiscal year 2005
(October 1, 2004 - September 30, 2005) based upon achievement of targets and objectives established by the Compensation Committee after consulting with EMPLOYEE. For purposes of this bonus, EMPLOYEE will be treated as if employed as of October 1,
2004. Payment and other conditions of this bonus shall be governed by the same conditions and policies applicable to other Senior Management members. After the first year, the timing, amount and conditions of a bonus will be determined by the
Compensation Committee after discussion with EMPLOYEE. 
  
 3.3. Stock Options. EMPLOYEE shall be eligible to participate in PSA’s stock option plan at the level established for the position held by EMPLOYEE, and to the extent generally made available to all other Senior
Management members of PSA, and in accordance with PSA’s stock option plan, irrespective of his ownership interest in PSA predating the date of this Agreement. EMPLOYEE’s initial grant shall be options to acquire 300,000 shares of PSA stock
priced at closing of the first day of EMPLOYEE’s employment. Based upon performance and business conditions, the Compensation Committee will determine the amount and the timing of any future grants of stock options.  
  
 3.4 Benefit Plans. During EMPLOYEE’s employment under this
Agreement and as otherwise provided herein, EMPLOYEE shall be entitled to participate in any and all employee welfare and health benefit plans (including, but not limited to, life insurance, health and medical, dental and disability plans) and other
employee benefit plans established by PSA from time to time for the benefit of all executives of PSA. EMPLOYEE shall be required to comply with the conditions attendant to coverage by such plans and shall comply with and be entitled to benefits only
in accordance with the terms and conditions of such plans as changed, modified or terminated by PSA from time to time. However, should PSA purchase a “key man” life insurance policy in the name of EMPLOYEE, the beneficiary shall be PSA or
its other designated beneficiary and such policy will not inure to the benefit of EMPLOYEE or his beneficiaries or heirs. 
  
 3.5 Vacations, Holidays and Other Benefits. EMPLOYEE shall be entitled to not less than three (3) weeks of paid vacation each year of his
employment, such amount to be accrued and used during EMPLOYEE’s then current year of employment. Unused and accrued vacation will be paid upon termination, whether involuntary or voluntary. Furthermore, EMPLOYEE shall be entitled to all
applicable holidays and to such other employment benefits extended or provided to Senior Management members. 
  
 3.6 Car Allowance. PSA shall pay EMPLOYEE $600.00 per month for a car allowance. This allowance will be subject to applicable withholdings
in accordance with IRS regulations. 
  
 3.7 Deductions from
Salary and Benefits. PSA may withhold from any salary or benefits payable to Employee all federal, state, local and other taxes and other amounts as permitted or required pursuant to federal and Georgia law, rule or regulation. 

 
 3.8 Non Qualified Deferred Compensation Plan. EMPLOYEE shall
become eligible for the Deferred Compensation Plan (the “DCP”) in accordance with the provisions of the DCP; in addition, PSA further acknowledges and agrees that, with respect to Section 2.1(C) of the Plan, EMPLOYEE shall be entitled to
participate in the Plan as of January 1, 2005. Without limiting EMPLOYEE’s entitlement to participate as of January 1, 2005, participation and benefits of the DCP are otherwise governed by its official plan documents as changed, modified or
terminated by PSA from time to time. 
  

 2 

 3.9 Employee Stock Purchase. EMPLOYEE shall become eligible to participate in PSA’s
Employee Stock Purchase plan in accordance with the provisions of the Plan. Participation and benefits of this Plan are governed by its official plan documents as changed, modified or terminated by PSA from time to time. 
  
 3.10 Payment of Premiums. EMPLOYEE owns a life insurance policy
with coverage in the face amount of $750,000 and a long-term disability policy with monthly coverage in the amount of $8,600 (collectively, the “Policies”). As an additional benefit hereunder, during EMPLOYEE’s employment by PSA, PSA
shall pay all premiums due under such Policies or due under any policies with comparable coverage reasonably substituted by EMPLOYEE in lieu thereof; provided, however, in no event shall PSA be obligated to pay in accordance with this Section 3.10
any: (a) life insurance policy premium in excess of Eleven Thousand Dollars ($11,000) per year; or, (b) long-term disability premium in excess of Three Thousand, Five Hundred Dollars ($3,500) per year. 
  
 IV. 
 PSA PROPERTY 
  
 4.1 Return of PSA Property. Upon termination of his employment with PSA, whether voluntary or involuntary, EMPLOYEE shall promptly deliver to PSA all of its property in his possession or under his
control, including among other things, all equipment, computers, notebooks, documents, memoranda, reports, photographs, files, books, correspondence, employee or other lists, calendars, card files, Rolodexes, and all other written, electronic, and
graphic records relating to PSA’s business. In the event EMPLOYEE does not return such items by the end of his last day employment, PSA will deduct the fair market value of such item(s) from his pay. 
  
 V. 
 RESTRICTIVE COVENANTS 
  
 5.1 Background. During his employment with PSA, EMPLOYEE will gain intimate knowledge of all aspects of PSA’s business, including its strategic plans and its financial information. In his role as
Chief Executive Officer of PSA, EMPLOYEE will develop ongoing business relationships with third-party payors (including, without limitation, Medicaid programs, the Medicare Program and various commercial payors) and patient referral sources in the
states in which PSA does business. Because of this knowledge and these relationships, PSA would suffer significant and irreparable harm if EMPLOYEE were to engage in the conduct prohibited by this Section V. Accordingly, EMPLOYEE agrees to the
following restrictions. The parties acknowledge and agree that the provisions of Section V will be non-binding and unenforceable in the event that: (a) EMPLOYEE is entitled to severance pay in accordance with either Section 6.4 or Section 6.5
herein; and, (b) PSA fails to make any of the severance payments as otherwise provided in Section 6.4 or Section 6.5, as applicable. 
  
 5.2 Noncompetition. During the Restricted Period, EMPLOYEE will not, directly or indirectly, on his own behalf or on behalf of another, act
in a capacity in which EMPLOYEE would perform the same or substantially the same duties EMPLOYEE performed for PSA on behalf of any competing business which engages in one or more of the Restricted Lines of Business (as defined below) in the
Restricted Territory (as defined below). This paragraph shall not restrict EMPLOYEE from acquiring not more than two percent (2%) of the common stock of any publicly-traded corporation. This paragraph also shall not restrict EMPLOYEE from becoming
employed by a business which engages in the Restricted Lines of Business as long as EMPLOYEE does not perform the same or substantially the same duties as EMPLOYEE performed for PSA and EMPLOYEE otherwise complies with the restrictions of this
Section. 
  

 3 

 5.3 Nonsolicitation of Employees. During the Restricted Period, EMPLOYEE will not, directly
or indirectly, on his own behalf or on behalf of another, solicit for employment, encourage or attempt to persuade any employee of PSA or its subsidiaries with whom EMPLOYEE had direct contact during his employment to terminate his/her employment
with PSA. “Direct contact” means interaction between EMPLOYEE and another employee of PSA or its subsidiaries for the purpose of performing or conducting PSA’s or its subsidiaries’ business. 
  
 5.4 Nonsolicitation of Customers and Referral Sources. During
the Restricted Period, EMPLOYEE will not, directly or indirectly, on his own behalf or on behalf of another, solicit any customer or referral source of PSA or its subsidiaries (as listed on Appendix 1) to terminate or modify to PSA’s or its
subsidiaries’ disadvantage such customer’s or referral source’s business relationship with PSA or its subsidiaries. This covenant is limited to customers and referral sources that are located or otherwise conduct business in the
Restricted Territory (as defined below). As to “customers,” this covenant is limited to solicitations in which EMPLOYEE offers products or services that are competitive with those offered by PSA and its subsidiaries (as listed on Appendix
1). As to “referral sources,” this covenant is limited to solicitation for the purpose of obtaining referrals of the same type as referrals PSA and its subsidiaries would seek from the referral source. 
  
 5.5 Definitions. For purposes of this Section, the following
terms shall have the following meanings: 
  
 (a) Restricted
Period. The Restricted Period shall refer to that period of time beginning on the date of termination of employment, whether voluntary or involuntary, with or without cause, and ending two calendar years later. 
  
 (b) Restricted Lines of Business. The Restricted Lines of
Business shall include the following business lines that PSA or its subsidiaries was operating as of the date of termination: (i) Pediatric Nursing Services; (ii) Care centers substantially similar to PSA’s Prescribed Pediatric
Extended Care Centers; (iii) Specialty Pharmacy and Infusion Therapy Services; (iv) Respiratory Therapy and Home Medical Equipment Services; or (v) Pediatric Case Management Services. 
  
 (c) Restricted Territory. The Restricted Territory is
the area that is within a 25-mile radius of each location of PSA or its subsidiaries that is listed on Appendix 2. 
  
 5.6 Remedies. The parties acknowledge that the restrictions contained in this Section are reasonable and appropriate for the protection of
PSA’s legitimate business interests, and that they will not unduly impair EMPLOYEE’S ability to find other employment. EMPLOYEE acknowledges and agrees that, in the event of a violation of one or more of EMPLOYEE’S covenants in this
Section, in addition to and not in lieu of any other remedy to which PSA may be entitled, PSA shall be permitted to seek and obtain immediate injunctive relief, restraining further violations of EMPLOYEE, in a court of competent jurisdiction, and
without the necessity for posting of a bond or other security. In addition to and not in lieu of any other remedy to which PSA may be entitled, no further payments or benefits of any kind that would otherwise inure to EMPLOYEE pursuant to Section
III of this Agreement shall accrue or be owed, and all future payments and benefits hereunder shall be forfeited, immediately upon EMPLOYEE’S violation of any of the covenants in Section V of this Agreement. 
  

 4 

 5.7 No Disclosure of Confidential Information. Unless required to do so in the normal
course of business, EMPLOYEE agrees not to use, disclose, or communicate to any person, firm, or corporation any confidential information learned by EMPLOYEE in the course and scope of employment with PSA while employed by PSA and for two (2) years
following termination, so long as such information remains confidential. “Confidential information” includes, but is not limited to: financial information and projections, strategic plans, business plans, organizational plans, markets,
sales, pricing policies, operational methods, customer lists, referral source lists, compensation or benefits paid to employees; terms or conditions of employment; human resource information or business related information contained in PSA’s
computer or other systems; any other information pertaining to PSA, its employees, customers and business, which is not a trade secret, not generally known to the public and has actual or potential economic value to PSA because such information is
generally not known by others. 
  
 5.8 No Disclosure of
Trade Secrets. EMPLOYEE agrees not to use, disclose or communicate to any person, firm, or corporation any trade secret learned by EMPLOYEE in the course and scope of employment with PSA while employed by PSA or at any time thereafter, so
long as such information remains a trade secret. A trade secret includes information defined as such by the Georgia Trade Secrets Act and the common law of the State of Georgia. 
  
 5.9 Other Legal Restrictions May Apply. The contractual restrictions on use and disclosure of confidential
information, trade secrets and intellectual property imposed by this Agreement are meant to supplement, not replace, any other restrictions and remedies which may apply under federal, state and/or local statutory and common law, including but not
limited to the attorney-client and attorney work product privileges. 
  
 VI. 
 TERM AND TERMINATION 
  
 6.1 Term. EMPLOYEE will be employed by PSA for no specific period of time on an “at-will” basis. EMPLOYEE’s tenure as a
Director will end upon termination of his employment with PSA, whether voluntary or involuntary, or if EMPLOYEE is not otherwise re-elected as a Director. 
  
 6.2 Termination for Good Cause. The employment of EMPLOYEE shall immediately terminate for “good cause” upon the occurrence of any
of the following events: 
  

	 	(a)	the death or disability of EMPLOYEE (disability means a physical or mental impairment of EMPLOYEE resulting in the anticipated or actual inability to perform his essential job
functions for a period of 90 consecutive days or more) as determined by PSA; 

  

	 	(b)	termination by PSA of EMPLOYEE’s employment, upon written notice to EMPLOYEE, for any of the following reasons: (i) EMPLOYEE commits or is convicted of, pleads guilty or nolo
contendere to, or confesses to a felony or act of fraud, theft, misappropriation, embezzlement, dishonesty or moral turpitude; (ii) any willful act or willful omission by EMPLOYEE involving malfeasance or intentional failure in the performance of
EMPLOYEE’s assigned duties to PSA; (iii) EMPLOYEE fails to satisfactorily perform duties and responsibilities reasonably assigned to him after being provided with notice and a reasonable opportunity to correct such performance deficiency and
such failure has a material and adverse affect on the business of PSA; (iv) EMPLOYEE commits a serious violation of a PSA rule, policy or procedure about which EMPLOYEE had 

  

 5 

 notice and such violation has a material and adverse affect on the business of PSA; (v) EMPLOYEE
otherwise fails to comply with the terms of this Agreement after being provided with notice and a reasonable opportunity to correct such failure [except with respect to sub-parts (i), (ii), (iv) and (vi) of this Section 6.2(b)] and, further, such
failure has a material and adverse affect on the business of PSA; or, (vi) EMPLOYEE commits or is convicted of, pleads guilty or nolo contendere to, or confesses to any violation of applicable securities laws and/or regulations. In the event
EMPLOYEE is charged with a crime, other than minor traffic violation, PSA may suspend Employee while the matter is investigated. If the matter is not resolved within thirty (30) days, PSA has the right to terminate Employee and such termination will
be considered for “good cause”. 
  
 6.3 Voluntary
or Good Cause Termination. If EMPLOYEE’S employment hereunder is terminated as a result of a voluntary resignation, mutual agreement of PSA and EMPLOYEE, or for “good cause,” as defined above, PSA shall have no further
obligation to pay to EMPLOYEE any Base Salary or provide any other additional benefits, including any portion of any bonus or incentive, except accrued but unused vacation or other paid time off, pursuant to this Agreement as of the date of the
termination of EMPLOYEE’s employment. In the event of a voluntary resignation, EMPLOYEE agrees to provide no less than two (2) weeks written notice. At PSA’s option, PSA may provide EMPLOYEE with a proportionate share of his base salary
for such notice period. EMPLOYEE will continue to be bound by the restrictive covenants set forth in Section V for the periods of time set forth therein. 
  
 6.4 Severance Upon Termination Without Good Cause. Should PSA terminate EMPLOYEE without “good cause” as defined above or should
EMPLOYEE terminate his employment for “good reason” as defined below, this Agreement will immediately end and EMPLOYEE shall be entitled to two years of his Base Salary, less appropriate withholdings and deductions, payable as severance
pay, paid as continued salary or in a lump sum at the option of PSA. These severance payments are conditioned upon EMPLOYEE executing a general release of claims in favor of PSA and its directors, officers, employees and related entities in the form
prescribed by PSA and EMPLOYEE’S continued compliance with the restrictive covenants set forth in Section V for the periods of time set forth therein. In the event that PSA reduces EMPLOYEE’s duties, authority, or compensation in
contravention of this Agreement and without good cause as defined above, then EMPLOYEE shall have the right to terminate his employment for “good reason” whereupon PSA shall be obligated for the payment of severance under this Section 6.4.

  
 6.5 Severance Upon Termination Due to a Change In
Control. 
  

	 	(a)	Should PSA or its successors and assigns terminate EMPLOYEE without good cause, as defined above, upon and due to a Change in Control of PSA, as defined in sub-paragraph (b) below,
EMPLOYEE shall be entitled to the severance benefits set forth in Section 6.4 above. For purposes of this Section 6.5, a substantial reduction in duties, authority or compensation due to a Change in Control without good cause as defined above,
constitutes a termination without cause, at the option of EMPLOYEE. In addition, all unexercised stock options granted to EMPLOYEE prior to the date of termination shall be deemed fully vested and the time for exercise of each of the respective
options shall be extended to the maximum time permitted for the exercise of each such option under Section 6.5 of the PSA Stock Option Plan. EMPLOYEE will continue to be bound by the restrictive covenants set forth in Section V for the periods of
time set forth therein. 

  

 6 

	 	(b)	“Change in Control” means the occurrence of any of the following: (i) any sale, lease, transfer, conveyance or other disposition (other than by way of merger or
consolidation) in one or a series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries taken as a whole to any “person” (as defined in Section 13(d) of the Exchange Act) or
“group” (as defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act); (ii) the adoption of a plan for the liquidation or dissolution of the Company or Pediatric Services of America, Inc., a Georgia corporation (“PSA-GA”);
(iii) the Company, PSA Capital Corporation, a Delaware corporation (“PSA-Capital”) or PSA-GA consolidates with, or merges with or into, another “person” (as defined above) or “group” (as defined above), in a transaction
or series of related transactions in which the voting stock of the Company, PSA-Capital or PSA-GA is converted into or exchanged for cash, securities or other property, other than any transaction where (A) the outstanding voting stock of the
Company, PSA-Capital or PSA-GA is converted into or exchanged for voting stock of the surviving or transferee corporation and (b) either (1) the “beneficial owners” (as defined in Rule 13d-3 and 13d-5 under the Exchange Act) of the
outstanding Voting Stock, of the Company, PSA-Capital or PSA-GA immediately prior to such transaction own beneficially, directly or indirectly through one or more Subsidiaries, not less than a majority of the total outstanding voting stock of the
surviving or transferee corporation immediately after such transaction or, (2) if immediately prior to such transaction the Company (except with respect to PSA-Capital or PSA-GA), PSA-Capital or PSA-GA is a direct or indirect Subsidiary of any other
Person (each such other Person, the “Holding Company”), the “beneficial owners” (as defined above) of the outstanding Voting Stock of such Holding Company immediately prior to such transaction own beneficially, directly or
indirectly through one or more Subsidiaries, not less than a majority of the outstanding voting stock of the surviving or transferee corporation immediately after such transaction; or (iv) the consummation of any transaction or series of related
transactions (including, without limitation, by way of merger or consolidation) the result of which is that any “person” (as defined above) or “group” (as defined above) becomes the “beneficial owner” (as defined above)
of more than 50% of the voting power of the voting stock of the Company, PSA-Capital or PSA-GA. 

  
 VII. 
 REMEDIES 
  
 7.1 Indemnification. Any party who breaches this Agreement
shall indemnify the other party for all costs, expenses, liabilities, attorneys’ fees and damages, in connection with such breach of this Agreement. PSA also agrees to provide EMPLOYEE with legal representation and to indemnify him against any
liabilities or costs of defending claims brought against him for acting within the scope of his employment, unless such conduct involves misconduct on the part of EMPLOYEE. 
  
 7.2 Election of Remedies. PSA or EMPLOYEE may elect to seek one or more of these remedies at their sole
discretion on a case-by-case basis. Failure to seek any or all remedies in one case does not restrict either party from seeking any remedies in another situation. Such an action by a party shall not constitute a waiver of any of its rights.

  

 7 

 VIII. 
 MISCELLANEOUS 
  
 8.1
Severability and Modification of Any Unenforceable Covenant. The parties intend that each section of this Agreement shall be read and interpreted with every reasonable inference given to its enforceability. However, the parties also
intend that if any provision of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the provisions herein shall remain in full force and effect and shall in no way be affected, impaired
or invalidated. Finally, the parties also intend that if a court should determine any restrictive covenant contained in this Agreement is unenforceable because of over breadth, then the court shall modify said covenant so as to make it reasonable
and enforceable under the circumstances. 
  
 8.2
Notice. Any notice, demand, consent or other commitment to be given hereunder shall be deemed given when personally delivered to the party to receive such notice in person, by facsimile or by email, or three (3) business days after being
mailed, postage prepaid, by registered or certified mail, as follows: 
  

			
	 If to PSA:
	 	If to Employee:
		
	 Attn: Chief Financial Officer
	 	Mr. Daniel J. Kohl
	 310 Technology Parkway
	 	3045 Merriweather Woods
	 Norcross, Georgia 30092
	 	Alpharetta, GA 30022
		
	 With a copy to:
	 	 
		
	 Attn: General Counsel
	 	 
	 310 Technology Parkway
	 	 
	 Norcross, Georgia 30092
	 	 

  
 Such addresses may be changed by
notice in writing to the other party. 
  
 8.3
Interpretation. This Agreement shall be deemed to be made in, and in all respects shall be interpreted, construed and governed by and in accordance with, the laws of the State of Georgia. No provision of this Agreement or any related
document shall be construed against or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party having or being deemed to have structured or drafted such provision.

  
 8.4 Headings. The section and paragraph
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
  
 8.5 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed to be an original but all of which
together shall constitute one and the same instrument. 
  
 8.6
Certification. EMPLOYEE certifies that EMPLOYEE has read the Agreement, studied it, had sufficient opportunity to ask questions, and understands all rights and obligations under the Agreement. EMPLOYEE also certifies that EMPLOYEE had the
option of seeking legal counsel regarding this Agreement prior to execution. 
  
 8.7 Assignment. This Agreement shall be binding upon and inure to the benefit of (a) the heirs, executors and legal representatives of EMPLOYEE upon EMPLOYEE’s death or incapacity, and (b)

  

 8 

 any successor or assign of PSA. Any such successor of PSA shall be deemed substituted for PSA under the terms of this
Agreement for all purposes. As used herein, “successor” shall include any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially
all of the assets of business of PSA. EMPLOYEE’s obligations under this Agreement are not assignable. None of the rights of EMPLOYEE to receive any form of compensation payable pursuant to this Agreement shall be assignable or transferable
except through a testamentary disposition or by the laws of descent and distribution upon the death of EMPLOYEE. Any attempted assignment, transfer, conveyance or other disposition (other than as aforesaid) of any interest in the rights of EMPLOYEE
to receive any form of compensation hereunder shall be null and void. 
  
 PSA shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of PSA to assume expressly and agree to perform this Agreement in the
same manner and to the same extent that PSA would be required to perform it if no such succession had taken place. 
  
 8.8 Arbitration and Equitable Relief. 
  
 (a) To the extent permitted by applicable law, EMPLOYEE agrees that any dispute or controversy arising out of, relating to, or in connection with
this Agreement, or the interpretation, validity, construction, performance, breach or termination thereof shall be settled by arbitration to be held in Fulton County, Georgia, in accordance with the National Rules for the Resolution of Employment
Disputes then in effect of the American Arbitration Association (the “Rules”). The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator shall be final, conclusive and binding on
the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. This provision and (b) and (c) below do not limit the right of PSA to seek injunctive relief in a court of competent
jurisdiction against Employee for a violation of any provision of this Agreement which has or is likely to cause PSA irreparable harm. 
  
 (b) The arbitrator shall apply Georgia law to the merits of any dispute or claim, without reference to rules of conflict of law. 
  
 (c) EMPLOYEE HAS READ AND UNDERSTANDS SECTION 8.8, WHICH DISCUSSES
ARBITRATION. EMPLOYEE UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, EMPLOYEE AGREES TO SUBMIT ANY FUTURE CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE, BREACH, OR
TERMINATION THEREOF TO BINDING ARBITRATION, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF EMPLOYEE’S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF THE EMPLOYER/EMPLOYEE RELATIONSHIP,
INCLUDING BUT NOT LIMITED TO, THE FOLLOWING CLAIMS: (i) ANY AND ALL CLAIMS FOR WRONGFUL DISCHARGE OF EMPLOYMENT; BREACH OF CONTRACT, BOTH EXPRESS OR IMPLIED; BREACH OF THE COVENANT OF GOOD FAITH AND FAIR DEALING, BOTH EXPRESS AND IMPLIED; NEGLIGENT
OR INTENTIONAL INFLICTION OF EMOTIONAL DISTRESS; NEGLIGENT OR INTENTIONAL MISREPRESENTATION; NEGLIGENT OR INTENTIONAL INTERFERENCE WITH CONTRACT OR PROSPECTIVE ECONOMIC ADVANTAGE; AND DEFAMATION. (ii) ANY AND ALL CLAIMS FOR VIOLATION OF ANY FEDERAL
STATE OR MUNICIPAL STATUTE, INCLUDING, BUT NOT LIMITED TO, TITLE VII OF THE CIVIL RIGHTS ACT 
  

 9 

 OF 1964, THE CIVIL RIGHTS ACT OF 1991, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE AMERICANS
WITH DISABILITIES ACT OF 1990, AND THE FAIR LABOR STANDARDS ACT; (iii) ANY AND ALL CLAIMS ARISING OUT OF ANY OTHER LAWS AND REGULATIONS RELATING TO ANY SUBJECT MATTER OF THIS AGREEMENT INCLUDING BUT NOT LIMITED TO EMPLOYMENT OR EMPLOYMENT
DISCRIMINATION. 
  

			
	 /s/ DJK

 EMPLOYEE’S
	  	 /s/ EKW

 PSA

	 INITIALS
	  	INITIALS

  
 8.9 Entire
Agreement. This Agreement and the documents referenced herein represent the entire agreement and understanding between PSA and EMPLOYEE concerning the subject matter hereof, and supersede and replace any and all prior agreements and
understandings concerning such subject matter. 
  
 IN WITNESS
WHEREOF, the parties hereto have executed this Agreement as of the day, month and year first set forth below each parties’ signature. 
  

					
	DANIEL J. KOHL (“EMPLOYEE”)	 	PEDIATRIC SERVICES OF AMERICA, INC. (“PSA”)
			
	 /s/ DANIEL J. KOHL

	 	BY:	 	 /s/ EDWARD K. WISSING

	 	 	 	 	Authorized Signature
			
	 	 	 	 	Edward K. Wissing
	 	 	
          Name (printed)

		
	 DATE: 1 December 2004
	 	DATE: 1 December 2004

	

	

  

 10 

 APPENDIX 1 
  
 List of Subsidiaries 
  

	1.	PSA Properties Corporation, a Delaware corporation; EIN: 52-2047069 

  

	2.	PSA Licensing Corporation, a Delaware corporation; EIN: 51-0375888 

  

	3.	PSA Capital Corporation, a Delaware corporation; EIN: 51-0383909 

  

	4.	Pediatric Services of America, Inc., a Georgia corporation; EIN: 58-1584862 

  

	5.	Pediatric Home Nursing Services, Inc., a New York corporation; EIN: 13-3865349 

  

	
	 /s/ DJK

 EMPLOYEE’S INITIALS

  

 11 

 APPENDIX 2 
  
 LIST OF COMPANY LOCATIONS AS OF EXECUTION DATE 
  

 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]